Reactions in leprosy are acute inflammatory episodes that can be classified as type I or type II. Recognition and timely management of these patients is critical to avoid permanent disability. We present two cases of erythema nodosum leprosum, presenting with recurrent atypical features, responding well to a low dose of methotrexate.
Walker SL, Sales AM, Butlin CR, et al. A leprosy clinical severity scale for erythema nodosum leprosum: an international, multicentre validation study of the ENLIST ENL Severity Scale. PLoS Negl Trop Dis 2017; 11: e0005716.
2.
Bhat RM and Prakash C. Leprosy: an overview of pathophysiology. Interdiscip Perspect Infect Dis 2012; 6: 181089.
3.
NaveenKNAthanikarSBHegdeSP, et al.Livedo reticularis in type 2 lepra reaction: a rare presentation. Ind Dermatol Online J2014; 5: 182–184.
4.
GunawanHYogyaYHafinahR, et al.Reactive perforating leprosy, erythema multiforme-like reactions, sweet's syndrome-like reactions as atypical clinical manifestations of Type 2 leprosy reaction. Int J Mycobacteriol2018; 7: 97–100.
5.
SgambattiSAndradeJSousaA, et al.An unusual presentation of leprosy at diagnosis: Erythema multiforme-like type 2 reaction. Rev Patalogia Trop2010; 39: 221–227.
6.
KouTTChanHL. Severe reactional state in lepromatous leprosy simulating Sweet's syndrome. Int J Dermatol1987; 26: 518–520.
7.
VijendranPVermaRVasudevanB, et al.Rare atypical presentations in Type 2 lepra reaction: a case series. Int J Dermatol2014; 53: 32–36.
8.
Chandra SekharSKananbalaSSwetalinaP, et al.Erythema nodosum leprosum (ENL) mimicking pityriasis lichenoides et varioliform acuta (PLEVA): an atypical presentation. Lepr Rev2018; 89: 310–315.
9.
GhorpadeA. Reactive perforating leprosy: pustular erythema nodosum leprosum with epidermal perforation and liberation of Mycobacterium leprae. Int J Dermatol2014; 53: 221–223.
10.
World Health Organization. WHO SEARO/Department of Control of Neglected Tropical Diseases. A guide for surveillance of antimicrobialresistance in leprosy: 2017 update. New Delhi: World Health Organisation, Regional Office for South-East Asia, 2017.
11.
PandhiDChhabraN. New insights in the pathogenesis of type 1 and type 2 lepra reaction. Ind J Dermatol Venereol Leprol2013; 79: 739–749.
12.
HossainD. Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients. Lepr Rev2013; 84: 105–112.
13.
KarBRBabuR. Methotrexate in resistant ENL. Int J Lepr Other Mycobact Dis2004; 72: 480–482.
14.
RahulNSanjayKSSinghS. Effectiveness of Methotrexate in prednisolone and thalidomide resistant cases of Type 2 lepra reaction: report on three cases. Lepr Rev2015; 86: 379–382.
